Literature DB >> 33629363

Accuracy of Japanese claims data in identifying diabetes-related complications.

Kazuya Fujihara1, Mayuko Yamada-Harada1, Yasuhiro Matsubayashi1, Masaru Kitazawa1, Masahiko Yamamoto1, Yuta Yaguchi1, Hiroyasu Seida2, Satoru Kodama1, Kohei Akazawa3, Hirohito Sone1.   

Abstract

PURPOSE: To evaluate the accuracy of various claims-based definitions of diabetes-related complications (coronary artery disease [CAD], heart failure, cerebrovascular disease and dialysis).
METHODS: We evaluated data on 1379 inpatients who received care at the Niigata University Medical & Dental Hospital in September 2018. Manual electronic medical chart reviews were conducted for all patients with regard to diabetes-related complications and were used as the gold standard. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of each claims-based definition associated with diabetes-related complications based on Diagnosis Procedure Combination (DPC), International Classification of Diseases, Tenth Revision (ICD-10) codes, procedure codes and medication codes were calculated.
RESULTS: DPC-based definitions had higher sensitivity, specificity, and PPV than ICD-10 code definitions for CAD and cerebrovascular disease, with sensitivity of 0.963-1.000 and 0.905-0.952, specificity of 1.000 and 1.000, and PPV of 1.000 and 1.000, respectively. Sensitivity, specificity, and PPV were high using procedure codes for CAD and dialysis, with sensitivity of 0.963 and 1.000, specificity of 1.000 and 1.000, and PPV of 1.000 and 1.000, respectively. DPC and/or ICD-10 codes + medication were better for heart failure than the ICD-10 code definition, with sensitivity of 0.933, specificity of 1.000, and PPV of 1.000. The PPVs were lower than 60% for all diabetes-related complications using ICD-10 codes only.
CONCLUSION: The DPC-based definitions for CAD and cerebrovascular disease, procedure codes for CAD and dialysis, and DPC or ICD-10 codes with medication codes for heart failure could accurately identify these diabetes-related complications from claims databases.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  claims-based diagnosis; complications; diabetes; pharmacoepidemiology; validity

Year:  2021        PMID: 33629363     DOI: 10.1002/pds.5213

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus.

Authors:  Yuta Suzuki; Hidehiro Kaneko; Akira Okada; Hidetaka Itoh; Satoshi Matsuoka; Katsuhito Fujiu; Nobuaki Michihata; Taisuke Jo; Norifumi Takeda; Hiroyuki Morita; Kentaro Kamiya; Atsuhiko Matsunaga; Junya Ako; Koichi Node; Hideo Yasunaga; Issei Komuro
Journal:  Cardiovasc Diabetol       Date:  2022-05-18       Impact factor: 8.949

2.  Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.

Authors:  Yasuhiro Matsubayashi; Kazuya Fujihara; Mayuko Yamada-Harada; Yurie Mitsuma; Takaaki Sato; Yuta Yaguchi; Taeko Osawa; Masahiko Yamamoto; Masaru Kitazawa; Takaho Yamada; Satoru Kodama; Hirohito Sone
Journal:  Cardiovasc Diabetol       Date:  2022-06-02       Impact factor: 8.949

3.  Associations of kidney tests at medical facilities and health checkups with incidence of end-stage kidney disease: a retrospective cohort study.

Authors:  Ryuichi Yoshimura; Ryohei Yamamoto; Maki Shinzawa; Rie Kataoka; Mina Ahn; Nami Ikeguchi; Natsuki Wakida; Hiroshi Toki; Toshiki Moriyama
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

4.  Endovascular versus open repair in patients with abdominal aortic aneurysm: a claims-based data analysis in Japan.

Authors:  Yuki Kimura; Hiroshi Ohtsu; Naohiro Yonemoto; Nobuyoshi Azuma; Kazuhiro Sase
Journal:  BMJ Surg Interv Health Technol       Date:  2022-07-29

5.  Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis.

Authors:  Hiroshi Ohtsu; Akihiko Shimomura; Sakiko Miyazaki; Naohiro Yonemoto; Shinichiro Ueda; Chikako Shimizu; Kazuhiro Sase
Journal:  Open Heart       Date:  2022-08

6.  Impact of prior cerebrovascular disease and glucose status on incident cerebrovascular disease in Japanese.

Authors:  Momoko Oe; Kazuya Fujihara; Mayuko Harada-Yamada; Taeko Osawa; Masaru Kitazawa; Yasuhiro Matsubayashi; Takaaki Sato; Yuta Yaguchi; Midori Iwanaga; Hiroyasu Seida; Takaho Yamada; Hirohito Sone
Journal:  Cardiovasc Diabetol       Date:  2021-09-03       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.